Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_L04AA
Extra metadata
List of similar endpoints to
L04AA Selective immunosuppressants
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4348 | 2681 | 1667 |
| Unadjusted prevalence (%) | 1.67 | 1.82 | 1.47 |
| Mean age at first event (years) | 49.32 | 48.97 | 49.87 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.03 | 1.75 [0.84, 3.64] | 1.4e-1 | 275 |
| 15 years | 0.02 | 2.44 [1.30, 4.57] | 5.3e-3 | 236 |
| 5 years | 0.00 | 3.77 [2.24, 6.35] | 6.3e-7 | 79 |
| 1 year | 0.00 | 2.97 [1.41, 6.26] | 4.1e-3 | 11 |
Index endpoint: RX_L04AA – L04AA Selective immunosuppressants
GWS hits:
before L04AA Selective immunosuppressants
after L04AA Selective immunosuppressants
Loading survival analyses plot
Loading survival analyses table